| David Joseph Gaffin | EVP, CLO, Alkermes, Inc. | Sale | 2026-08-03 | 2,034 | $99K |
| Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Sale | 2026-08-03 | 9,000 | $437K |
| Nancy Lynn Snyderman MD | — | Sale | 2026-08-03 | 44,472 | $2.2M |
| David Joseph Gaffin | EVP, CLO, Alkermes, Inc. | Sale | 2026-07-06 | 2,034 | $110K |
| Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Sale | 2026-07-01 | 9,000 | $464K |
| Christopher I Wright | — | Sale | 2026-06-12 | 2,000 | $90K |
| David Joseph Gaffin | EVP, CLO, Alkermes, Inc. | Sale | 2026-06-04 | 2,034 | $88K |
| Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Sale | 2026-06-01 | 9,000 | $375K |
| Samuel Joseph Parisi | VP, Finance (Interim PAO) | Sale | 2026-05-29 | 16,217 | $687K |
| Christopher I Wright | — | Tax Withhold | 2026-05-21 | 1,475 | $55K |
| Frank Anders Wilson | — | Tax Withhold | 2026-05-21 | 1,475 | $55K |
| Nancy Lynn Snyderman MD | — | Tax Withhold | 2026-05-21 | 1,475 | $55K |
| Brian P Mckeon | — | Tax Withhold | 2026-05-21 | 1,475 | $55K |
| Nancy Lurker | — | Tax Withhold | 2026-05-21 | 1,475 | $55K |
| Cato T Laurencin | — | Tax Withhold | 2026-05-21 | 1,475 | $55K |
| Richard Gaynor | — | Tax Withhold | 2026-05-21 | 1,475 | $55K |
| Shane Cooke | — | Tax Withhold | 2026-05-21 | 3,207 | $118K |
| David Joseph Gaffin | EVP, CLO, Alkermes, Inc. | Sale | 2026-05-04 | 2,034 | $68K |
| Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Sale | 2026-05-01 | 9,000 | $301K |
| Nancy Lurker | — | Tax Withhold | 2026-04-11 | 901 | $30K |
| David Joseph Gaffin | EVP, CLO, Alkermes, Inc. | Sale | 2026-04-06 | 2,034 | $70K |
| Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Sale | 2026-04-01 | 9,000 | $320K |
| Samuel Joseph Parisi | VP, Finance (Interim PAO) | Sale | 2026-03-02 | 6,890 | $202K |
| Christian Todd Nichols | SVP, Chief Commercial Officer | Sale | 2026-03-02 | 6,000 | $180K |
| Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Sale | 2026-03-02 | 9,000 | $267K |